BVI Medical Claimed Company
At BVI, we are at the forefront of innovation in ophthalmic surgery, delivering cutting-edge solutions that enhance patient care and improve vision outcomes. With a global presence in over 90 countries, we tailor our eye care offerings to meet the unique needs of local markets, while contributing to the betterment of global eye health. read more
HR or Marketing? Claim Your Free Employer Account
Andy Chang — Chief Commercial Officer at BVI Medical
Executive Bio
Andrew Chang brings over 20 years of commercial leadership experience in the ophthalmic medical device and pharmaceutical sectors, having held senior roles across some of the industry’s most recognised global organisations.
Chang began his career in finance and early-stage business roles before transitioning into the ophthalmic space. During his time at ISTA, he helped drive the successful introduction of multiple ophthalmic pharmaceutical products. Following the acquisition of ISTA by Bausch + Lomb, he took on broader responsibilities at OptiMedica which sold to Abbott Medical Optics shortly after. Eventually, he served as General Manager and Senior Vice President for Bausch + Lomb Surgical, overseeing U.S. sales, marketing, operations, and business development.
He later joined ZEISS Medical Technology, playing a key role in expanding ZEISS’s global footprint and driving sustained commercial growth.
Beyond his executive leadership roles, Andrew is a passionate advocate for innovation in ophthalmology. He currently serves on industry and advisory boards, the ASCRS Foundation, the Ophthalmology Foundation, Medical Device Manufacturers Association (MDMA), CEDARS/ASPENS Industry Committee, AECOS Executive Committee, Ophthalmic World Leaders (OWL), EyeSustain and is a founding member of the Vanguard Ophthalmology Society. In the past, he served on the board of MicroOptx, President and board of FCI Ophthalmics Inc / FCI SAS, and American Glaucoma Society Foundation.
Chang began his career in finance and early-stage business roles before transitioning into the ophthalmic space. During his time at ISTA, he helped drive the successful introduction of multiple ophthalmic pharmaceutical products. Following the acquisition of ISTA by Bausch + Lomb, he took on broader responsibilities at OptiMedica which sold to Abbott Medical Optics shortly after. Eventually, he served as General Manager and Senior Vice President for Bausch + Lomb Surgical, overseeing U.S. sales, marketing, operations, and business development.
He later joined ZEISS Medical Technology, playing a key role in expanding ZEISS’s global footprint and driving sustained commercial growth.
Beyond his executive leadership roles, Andrew is a passionate advocate for innovation in ophthalmology. He currently serves on industry and advisory boards, the ASCRS Foundation, the Ophthalmology Foundation, Medical Device Manufacturers Association (MDMA), CEDARS/ASPENS Industry Committee, AECOS Executive Committee, Ophthalmic World Leaders (OWL), EyeSustain and is a founding member of the Vanguard Ophthalmology Society. In the past, he served on the board of MicroOptx, President and board of FCI Ophthalmics Inc / FCI SAS, and American Glaucoma Society Foundation.
Executive Team Culture Ratings from BVI Medical Employees
TOP
10%
BVI Medical's Executive Team scores in the Top 10%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at BVI MedicalNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at BVI MedicalBVI Medical's Executive Team at a Glance
Based on 18 ratings, BVI Medical's employees are very satisfied with their Executive Team and give them an “A” or 79/100.
BVI Medical's Executive Team ranks in the Top 20% of other companies in Boston and Top 10% of other companies on Comparably that also have 1,001-5,000 Employees.
×